Corient Private Wealth
RMD icon

Corient Private Wealth’s ResMed RMD Stock Holding History

Corient Private Wealth’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.7M Sell
92,502
-92,282
-50% -$23M 0.03% 393
2025
Q4 		$41.8M Buy
184,784
+99,546
+117% +$25.5M 0.03% 399
2025
Q3 		$23.3M Sell
85,238
-1,523
-2% -$416K 0.04% 362
2025
Q2 		$22.4M Buy
86,761
+1,329
+2% +$317K 0.03% 372
2025
Q1 		$19.1M Buy
85,432
+2,448
+3% +$571K 0.03% 396
2024
Q4 		$19M Sell
82,984
-2,974
-3% -$716K 0.03% 399
2024
Q3 		$21M Buy
85,958
+5,298
+7% +$1.18M 0.03% 410
2024
Q2 		$15.4M Sell
80,660
-826
-1% -$168K 0.03% 436
2024
Q1 		$16.1M Buy
81,486
+15,552
+24% +$2.85M 0.03% 428
2023
Q4 		$11.3M Buy
65,934
+1,413
+2% +$217K 0.02% 488
2023
Q3 		$9.55M Buy
64,521
+10,892
+20% +$1.97M 0.02% 490
2023
Q2 		$11.7M Sell
53,629
-53
-0.1% -$11.8K 0.03% 450
2023
Q1 		$11.8M Buy
53,682
+39,559
+280% +$8.58M 0.03% 411
2022
Q4 		$2.94M Buy
+14,123
New +$3.1M 0.01% 612

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Corient Private Wealth's RMD Position: Q1 2026 in Review

Corient Private Wealth reduced its ResMed (RMD) stake by 50% in Q1 2026, selling an estimated $23M and leaving 92,502 shares worth $20.7M. The position accounts for 0.03% of the portfolio, ranked #393.

Corient Private Wealth first reported a position in RMD in Q4 2022 and has held it in 14 quarters since. The position peaked at $41.8M in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Corient Private Wealth held 92,502 shares of ResMed worth $20.7M as of Q1 2026.
  • Corient Private Wealth sold 92,282 ResMed shares in Q1 2026, an estimated $23M.
  • ResMed made up 0.03% of Corient Private Wealth's portfolio in Q1 2026, its #393 holding.
  • Corient Private Wealth first reported a position in ResMed in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's ResMed position peaked at $41.8M in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.